CARDIOVASCULAR DISEASES AND DEPRESSION. TREATMENT AND PREVENTION IN PSYCHOCARDIOLOGY

1. Introduction
2. Epidemiology of Cardiovascular Disease and Depression
3. The Risk Relationship Between Depression and CVD During Ageing
4. Mechanisms Linking Depression to Cardiovascular Disease: What Do Epidemiological Studies Tell Us?
5. Anxiety and the Effects on Cardiovascular Disease
6. A Clinical Cardiology Perspective of Psychocardiology
7. The Validity of Vascular Depression as a Diagnostic Construct
8. Mental Stress-Induced Myocardial Ischemia
9. Neuropsychological Impairment of Patients with Depression
10. Neuroimaging of Risk Factors of Depression and Cardiovascular Disease
11. Heart Rate Variability, Affective Disorders and Health
12. Arterial Stiffness in the Depression and Cardiovascular Comorbidity
13. Depression and Markers of Arteriosclerosis: Cross-Sectional Analyses of the Baseline Examination of the BiDirect Cohort Study
14. Metabolic-Inflammation Aspects of Depression and Cardiovascular Disease
15. Genetic Overlap Between Depression and Cardiometabolic Disorders
16. Emotional Word Processing in Cardiovascular Disease, Depression, and Depression Subtypes
17. Nutrition and Depression: Current Evidence on the Association of Dietary Patterns with Depression and Its Subtypes
18. Cardiometabolic Risk and Monitoring in Psychiatric Disorders
19. Monitoring for Metabolic Dysfunction and Cardiovascular Disease in Bipolar Disorder: A Shared Illness Process Approach
20. Assessment and Psychological Interventions for Depression Comorbid with Cardiovascular Disease
21. Moving Beyond Mood: Is it Time to Recommend Cognitive Training for Depression in Older Adults?
22. The Internet and Mobile Technology: A Platform for Behavior Change and Intervention in Depression and CVDs
23. Pharmacological Treatment and Prevention of Cardiovascular Diseases and Depression Comorbidity: Understanding Epidemiological, Clinical Trial Evidence, and the Biological Underpinnings
24. Anti-inflammatory Agents for the Treatment of Depression in the Light of Comorbid Cardiovascular Disease
25. The Use of Complementary Alternative and Integrative Medicine (CAIM) for Treatment and Prevention of Late-Life Depression and Cardiovascular Disease
26. An Integrative Psychosomatic Approach to the Treatment of Patients with Cardiovascular Diseases: Concepts and Experiences of a Dedicated Psychocardiology Ward at the University of Göttingen Medical Center
27. Prevention of CVD in Depression
28. Screening for Depression in Coronary Heart Disease: Detection of Early Disease States

The world is witnessing a burgeoning global epidemic of chronic cerebro- and cardiovascular disease and depression disorders. The reader will find this comprehensive book to be a long-needed, up-to-date knowledge base on these increasingly recognized comorbid conditions that have long-term consequences for individual function and well-being and society in general. This comprehensive book outlines the complex and bidirectional relationship between various types of depression and cerebro- and cardiovascular diseases. It is written by a range of experts in the field, including psychiatrists, cardiologists, neuroscientists, psychologists, and epidemiologists, with the aim of presenting and discussing the most recent evidence on the pathophysiology, neurobiology, and clinical presentation of these common and disabling comorbid conditions and the available pharmacological, psychological, and behavioral interventions. By elucidating the underlying clinical and neurobiological mechanisms in the brain and the rich interplay between the body and the brain biology, the book brings together the latest knowledge of this overlapping area in Psychiatry and Cardiology. The clear descriptions of evidence-based approaches to clinical treatment ensure that it will serve as both an up-to-date overview and a future guide for practicing clinicians and graduate students.

Features
• Examines the bidirectional relationship between depression and cerebro- and cardiovascular diseases
• Describes clinical treatment, early identification, and potential for prevention
• Considers important comorbidities of depression that may influence cerebro- and cardiovascular disease outcomes
• Explains long-term functional consequences of psychiatric and cerebro- and cardiovascular comorbidity